A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy

References

• Kestin LL, Goldstein NS, Vicini FA, et al. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys. 2002;54:686–697.
   PubMed Web of Science ®Google Scholar
• McPartlin AJ, Li XA, Kershaw LE, et al. MRI-guided prostate adaptive radiotherapy: a systematic review. Radiother Oncol. 2016;119:371–380.
   PubMed Web of Science ®Google Scholar
• Boer J, Herk M, Pos FJ, et al. Hybrid registration of prostate and seminal vesicles for image guided radiation therapy. Int J Radiat Oncol Biol Phys. 2012;86:177–182.
   Web of Science ®Google Scholar
• Thörnqvist S, Hysing LB, Zolnay AG, et al. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer. Radiother Oncol. 2013;109:344–349.
   PubMed Web of Science ®Google Scholar
• Groenendaal G, Borren A, Moman MR, et al. Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. Int J Radiat Oncol Biol Phys. 2012;82:537–544.
   PubMed Web of Science ®Google Scholar
• Appayya MB, Johnston EW, Punwani S. The role of multi-parametric MRI in loco-regional staging of men diagnosed with early prostate cancer. Curr Opin Urol. 2015;25:510–517.
   PubMed Web of Science ®Google Scholar
• Lips IM, van der Heide UA, Haustermans K, et al. Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial. Trials. 2011;12:255.
   PubMed Web of Science ®Google Scholar
• Borren A, Groenendaal G, Monan MR, et al. Accurate prostate tumor detection with multiparametric magnetic resonance imaging: dependence on histological properties. Acta Oncol. 2013;53:88–95.
   PubMed Web of Science ®Google Scholar
• van der Heide UA, Korporaal JG, Groenendaal G, et al. Functional MRI for tumor delineation in prostate radiation therapy. Imaging Med. 2011;3:219–231.
   Google Scholar
• Feuvret L, Noel G, Mazeron J, et al. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006;64:333–342.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measurements (ICRU). Report 83: prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU 2010;10:1–106.
   Google Scholar
• Michalski JM, Gay H, Jackson A, et al. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76:123–129.
   PubMed Web of Science ®Google Scholar
• Liu M, Moiseenko V, Agranovich A, et al. Normal tissue complication probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: a test of the QUANTEC-recommended NTCP model. Acta Oncol. 2010;49:1–10.
   Web of Science ®Google Scholar
• Cheung MR, Tucker SL, Gong L, et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007;67:1059–1065.
   PubMed Web of Science ®Google Scholar
• Vogelius IR, Bentzen SM. In response to Dr. Williams. Int J Radiat Oncol Biol Phys. 2010;80:639–640.
   Web of Science ®Google Scholar
• Diez P, Vogelius IS, Bentzen SM. A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer. Int J Radiat Oncol Biol Phys. 2010;77:1066–1071.
   PubMed Web of Science ®Google Scholar
• Sveistrup J, Munck af Rosenschöld P, Deasy JO, et al. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Radiat Oncol. 2014;9:44.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Yorke ED, Marks LB, et al. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76:116–122.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Muren LP, Bentzen L, et al. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncol. 2013;52:521–527.
   PubMed Web of Science ®Google Scholar
• Groenendaal G, van den Berg CAT, Korporaal JG, et al. Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. Radiother Oncol. 2010;95:185–190.
   PubMed Web of Science ®Google Scholar
• Hara N, Okuizumi M, Koike H, et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate. 2005;62:140–147.
   PubMed Web of Science ®Google Scholar
• Ghafoori M, Alavi M, Shakiba M, et al. The value of prostate MRI with endorectal coil in detecting seminal vesicle involvement in patients with prostate cancer. Iran J Radiol. 2015;12:e14556.
   Google Scholar
• Mazaheri Y, Varga HA, Nyman G, et al. Image artifacts on prostate diffusion-weighted magnetic resonance imaging: trade-offs at 1.5 Tesla and 3.0 Tesla. Acta Radiol. 2013;20:1041–1047.
   Google Scholar
• Heemsbergen WD, Hoogeman MS, Witte MG, et al. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy. Int J Radiat Oncol Biol Phys. 2007;67:1418–1424.
   PubMed Web of Science ®Google Scholar
• Engels B, Soete G, Verellen D, et al. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys. 2009;74:388–391.
   PubMed Web of Science ®Google Scholar